Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management

Key Findings

• ●Updated WHO 2022 and ICC criteria for SM diagnosis
• ●KIT D816V VAF >=10% now a B-finding
• ●CD30 added as minor criterion
• ●Avapritinib approved for ISM

Referenced in (1 disease)

No validation events recorded yet. Source will be checked on the next kipine-source-validator run.